SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wennberg JE, Fisher ES, Goodman DC, Skinner JS. Tracking the care of patients with severe chronic illness. The Dartmouth Atlas of Health Care 2008. Lebanon, NH: The Dartmouth Institute for Health Policy and Clinical Practice; 2008. Available at: http://www.dartmouthatlas.org/atlases/2008_Chronic_Care_Atlas.pdf Accessed April 13, 2008.
  • 2
    FoleyKM, GelbandH, eds. Improving Palliative Care for Cancer. Washington, DC: National Academy Press; 2001.
  • 3
    Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315-321.
  • 4
    Barnato AE, Herndon MB, Anthony DL, et al. Are regional variations in end-of-life care intensity explained by patient preferences? A Study of the US Medicare Population. Med Care. 2007; 45: 386-393.
  • 5
    National Comprehensive Cancer Network. Practice Guidelines in Oncology, v. 2.2005. Palliative Care. Available at: http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf Accessed May 14, 2007.
  • 6
    National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care. Pittsburgh, PA: National Consensus Project for Quality Palliative Care; 2004. Available at: http://www.nationalcon sensusproject.org Accessed May 14, 2007.
  • 7
    O'Reilly KB. California law mandates discussing end-of-life options. Am Med News. November 10, 2008. Available at: http://www.ama-assn.org/amednews/2008/11/10/prsc1110.htm Accessed December 17, 2008.
  • 8
    Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004; 22: 2992-2996.
  • 9
    Keating NL, Landrum MB, Klabunde CN, et al. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol. 2008; 26: 2532-2537.
  • 10
    Bradley EH, Cicchetti DV, Fried TR, et al. Attitudes about care at the end of life among clinicians: a quick, reliable, and valid assessment instrument. J Palliat Care. 2000; 16: 6-14.
  • 11
    Bradley EH, Cramer LD, Bogardus ST Jr, Kasl SV, Johnson-Hurzeler R, Horwitz SM. Physicians' ratings of their knowledge, attitudes, and end-of-life-care practices. Acad Med. 2002; 77: 305-311.
  • 12
    He Y, Zaslavsky AM, Harrington DP, Catalano PJ, Landrum MB. Imputation in a multiformat and multiwave survey of cancer care. Statist Methods in Medical Rsrch. In press.
  • 13
    Little RJ. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1986.
  • 14
    Little RJ. Direct standardization: a tool for teaching linear models for unbalanced data. Am Stat. 1982; 36: 38-43.
  • 15
    Lorenz KA, Lynn J, Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008; 148: 147-159.
  • 16
    Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000; 284: 2476-2482.
  • 17
    Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG. Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest. 2002; 122: 356-362.
  • 18
    Miles SH, Koepp R, Weber EP. Advance end-of-life treatment planning. A research review. Arch Intern Med. 1996; 156: 1062-1068.
  • 19
    Hagerty RG, Butow PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004; 22: 1721-1730.
  • 20
    Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA. 1995; 274: 820-825.
  • 21
    Reilly BM, Magnussen CR, Ross J, Ash J, Papa L, Wagner M. Can we talk? Inpatient discussions about advance directives in a community hospital. Attending physicians' attitudes, their inpatients' wishes, and reported experience. Arch Intern Med. 1994; 154: 2299-2308.
  • 22
    Haas JS, Weissman JS, Cleary PD, et al. Discussion of preferences for life-sustaining care by persons with AIDS. Predictors of failure in patient-physician communication. Arch Intern Med. 1993; 153: 1241-1248.
  • 23
    Shmerling RH, Bedell SE, Lilienfeld A, Delbanco TL. Discussing cardiopulmonary resuscitation: a study of elderly outpatients. J Gen Intern Med. 1988; 3: 317-321.
  • 24
    Hofmann JC, Wenger NS, Davis RB, et al. Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med. 1997; 127: 1-12.
  • 25
    Lamont EB, Siegler M. Paradoxes in cancer patients' advance care planning. J Palliat Med. 2000; 3: 27-35.
  • 26
    Gordon EJ, Daugherty CK. “Hitting you over the head”: oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003; 17: 142-168.
  • 27
    Helft P, Hlubocky F, Wen M, Daugherty CK. Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase 1 clinical trials. Support Care Cancer. 2003; 11: 644-651.
  • 28
    Song MK. Effects of end-of-life discussions on patients' affective outcomes. Nurs Outlook. 2004; 52: 118-125.
  • 29
    Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665-1673.
  • 30
    Mount BM. Dealing with our losses. J Clin Oncol. 1986; 4: 1127-1134.
  • 31
    Yabroff KR, Mandelblatt JS, Ingham J. The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med. 2004; 18: 202-216.
  • 32
    Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002; 346: 1061-1066.
  • 33
    Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006; 24: 3490-3496.
  • 34
    Harrington SE, Smith TJ. The role of chemotherapy at the end of life: “when is enough, enough?” JAMA. 2008; 299: 2667-2678.
  • 35
    Teno JM, Fisher ES, Hamel MB, Coppola K, Dawson NV. Medical care inconsistent with patients' treatment goals: association with 1-year Medicare resource use and survival. J Am Geriatr Soc. 2002; 50: 496-500.
  • 36
    Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med. 2003; 138: 639-643.
  • 37
    Wright AA, Katz IT. Letting go of the rope-aggressive treatment, hospice care, and open access. N Engl J Med. 2007; 357: 324-327.
  • 38
    Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003; 327: 195.
  • 39
    Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001; 134: 1096-1105.
  • 40
    Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998; 279: 1709-1714.
  • 41
    Haidet P, Hamel MB, Davis RB, et al. Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med. 1998; 105: 222-229.
  • 42
    Gomes B, Higginson IJ. Factors influencing death at home in terminally ill patients with cancer: systematic review. BMJ. 2006; 332: 515-521.
  • 43
    Karlsen S, Addington-Hall J. How do cancer patients who die at home differ from those who die elsewhere? Palliat Med. 1998; 12: 279-286.
  • 44
    Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med. 2005; 142: 260-273.
  • 45
    McCarthy EP, Burns RB, Ngo-Metzger Q, Davis RB, Phillips RS. Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA. 2003; 289: 2238-2245.
  • 46
    Keating NL, Landrum MB, Lamont EB, Earle CC, McNeil BJ. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer. In press.
  • 47
    Wennberg JE, Cooper MM. The Dartmouth Atlas of Health Care, 1998. Hanover, NH: Center for Evaluative Clinical Sciences, Dartmouth Medical School; 1998.
  • 48
    Covinsky KE, Fuller JD, Yaffe K, et al. Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc. 2000; 48: S187-S193.
  • 49
    Robinson K, Sutton S, von Gunten CF, et al. Assessment of the Education for Physicians on End-of-Life Care (EPEC) Project. J Palliat Med. 2004; 7: 637-645.
  • 50
    National Cancer Institute. Education for Physicians on End-of-Life Care-Oncology (EPEC-O). Bethesda, MD: National Cancer Institute; on December 17, 2007. Available at: http://www.cancer.gov/aboutnci/epeco Accessed on December 17, 2008.